女性性機能障害治療の世界市場 2023-2027

当レポートでは女性性機能障害治療の市場規模は、2023年から2027年の間に77億6,077万米ドルの増加が見込まれ、予測期間中に34.28%のCAGRで成長すると予測しています。当レポートでは、女性性機能障害治療市場について、全体的な分析、市場規模・予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析を行っています。

現在の世界の市場動向と促進要因、市場全体の環境に関する最新の分析を提供しています。

市場は、慢性疾患の蔓延、女性性機能障害治療に対する意識の高まり、低活動性性欲障害の治療薬の承認と入手可能性によって牽引されています。

本調査では、今後数年間における女性性機能障害治療市場の成長を牽引する主要な理由の一つとして、女性の性機能障害治療のための研究開発の増加を挙げています。また、女性性機能障害治療のための安全ラベルの変更と、女性の性機能障害の原因となる薬剤の使用の増加が、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界の女性性機能障害治療市場2017年～2021年
• 年齢層セグメント分析2017-2021
• 製品セグメント分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 年齢層別の市場セグメンテーション

• 市場内訳
• 年代別比較
• 40歳以上 - 市場規模と予測 2022-2027
• 40歳未満 - 市場規模と予測 2022-2027
• 年齢層別の市場機会

第7章 製品別の市場セグメンテーション

• 市場内訳
• 製品別比較
• 非ホルモン療法 - 市場規模と予測 2022-2027
• ホルモン療法 - 市場規模と予測 2022-2027
• 製品別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• フランス - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Cipla Ltd.
• Dare Bioscience Inc.
• Dr Reddys Laboratories Ltd.
• Duchesnay Inc.
• Endo International Plc
• Freya Pharma Solutions B.V.
• Lupin Ltd.
• Mithra Pharmaceuticals SA
• Novo Nordisk AS
• Palatin Technologies Inc.
• Pfizer Inc.
• Sprout Pharmaceuticals Inc.
• Strategic Science and Technologies LLC
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Age Group
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global female sexual dysfunction treatment market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Age Group - Market share 2022-2027 (%)
• Exhibits31: Data Table on Age Group - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Age Group
• Exhibits33: Data Table on Comparison by Age Group
• Exhibits34: Chart on Above 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Above 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Above 40 years - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Above 40 years - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Below 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Below 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Below 40 years - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Below 40 years - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Age Group ($ million)
• Exhibits43: Chart on Product - Market share 2022-2027 (%)
• Exhibits44: Data Table on Product - Market share 2022-2027 (%)
• Exhibits45: Chart on Comparison by Product
• Exhibits46: Data Table on Comparison by Product
• Exhibits47: Chart on Non-hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Data Table on Non-hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Chart on Non-hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibits50: Data Table on Non-hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibits51: Chart on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Data Table on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Chart on Hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibits54: Data Table on Hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibits55: Market opportunity by Product ($ million)
• Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits59: Chart on Geographic comparison
• Exhibits60: Data Table on Geographic comparison
• Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits97: Market opportunity By Geographical Landscape ($ million)
• Exhibits98: Impact of drivers and challenges in 2022 and 2027
• Exhibits99: Overview on Criticality of inputs and Factors of differentiation
• Exhibits100: Overview on factors of disruption
• Exhibits101: Impact of key risks on business
• Exhibits102: Vendors covered
• Exhibits103: Matrix on vendor position and classification
• Exhibits104: Cipla Ltd. - Overview
• Exhibits105: Cipla Ltd. - Business segments
• Exhibits106: Cipla Ltd. - Key news
• Exhibits107: Cipla Ltd. - Key offerings
• Exhibits108: Cipla Ltd. - Segment focus
• Exhibits109: Dare Bioscience Inc. - Overview
• Exhibits110: Dare Bioscience Inc. - Product / Service
• Exhibits111: Dare Bioscience Inc. - Key offerings
• Exhibits112: Dr Reddys Laboratories Ltd. - Overview
• Exhibits113: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits114: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits115: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits116: Duchesnay Inc. - Overview
• Exhibits117: Duchesnay Inc. - Product / Service
• Exhibits118: Duchesnay Inc. - Key offerings
• Exhibits119: Endo International Plc - Overview
• Exhibits120: Endo International Plc - Business segments
• Exhibits121: Endo International Plc - Key news
• Exhibits122: Endo International Plc - Key offerings
• Exhibits123: Endo International Plc - Segment focus
• Exhibits124: Freya Pharma Solutions B.V. - Overview
• Exhibits125: Freya Pharma Solutions B.V. - Product / Service
• Exhibits126: Freya Pharma Solutions B.V. - Key offerings
• Exhibits127: Lupin Ltd. - Overview
• Exhibits128: Lupin Ltd. - Product / Service
• Exhibits129: Lupin Ltd. - Key news
• Exhibits130: Lupin Ltd. - Key offerings
• Exhibits131: Mithra Pharmaceuticals SA - Overview
• Exhibits132: Mithra Pharmaceuticals SA - Product / Service
• Exhibits133: Mithra Pharmaceuticals SA - Key offerings
• Exhibits134: Novo Nordisk AS - Overview
• Exhibits135: Novo Nordisk AS - Business segments
• Exhibits136: Novo Nordisk AS - Key offerings
• Exhibits137: Novo Nordisk AS - Segment focus
• Exhibits138: Palatin Technologies Inc. - Overview
• Exhibits139: Palatin Technologies Inc. - Product / Service
• Exhibits140: Palatin Technologies Inc. - Key offerings
• Exhibits141: Pfizer Inc. - Overview
• Exhibits142: Pfizer Inc. - Product / Service
• Exhibits143: Pfizer Inc. - Key news
• Exhibits144: Pfizer Inc. - Key offerings
• Exhibits145: Sprout Pharmaceuticals Inc. - Overview
• Exhibits146: Sprout Pharmaceuticals Inc. - Product / Service
• Exhibits147: Sprout Pharmaceuticals Inc. - Key offerings
• Exhibits148: Strategic Science and Technologies LLC - Overview
• Exhibits149: Strategic Science and Technologies LLC - Product / Service
• Exhibits150: Strategic Science and Technologies LLC - Key offerings
• Exhibits151: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits152: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits153: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits154: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits155: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits156: Viatris Inc. - Overview
• Exhibits157: Viatris Inc. - Business segments
• Exhibits158: Viatris Inc. - Key offerings
• Exhibits159: Viatris Inc. - Segment focus
• Exhibits160: Inclusions checklist
• Exhibits161: Exclusions checklist
• Exhibits162: Currency conversion rates for US$
• Exhibits163: Research methodology
• Exhibits164: Validation techniques employed for market sizing
• Exhibits165: Information sources
• Exhibits166: List of abbreviations

Technavio has been monitoring the female sexual dysfunction treatment market and it is poised to grow by $7760.77 mn during 2023-2027, accelerating at a CAGR of 34.28% during the forecast period. Our report on the female sexual dysfunction treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, growing awareness of female sexual dysfunction, and approval and availability of drugs to treat hypoactive sexual desire disorder.

Technavio's female sexual dysfunction treatment market is segmented as below:

By Age Group

• Above 40 years
• Below 40 years

By Product

• Non-hormonal therapy
• Hormonal therapy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing R&D for the treatment of sexual dysfunction in women as one of the prime reasons driving the female sexual dysfunction treatment market growth during the next few years. Also, safety label changes for female sexual dysfunction therapy and increasing use of drugs causing sexual dysfunction in women will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the female sexual dysfunction treatment market covers the following areas:

• Female sexual dysfunction treatment market sizing
• Female sexual dysfunction treatment market forecast
• Female sexual dysfunction treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading female sexual dysfunction treatment market vendors that include Assos Ilac, Cipla Ltd., Dare Bioscience Inc., Dr Reddys Laboratories Ltd., Duchesnay Inc., Endo International Plc, Freya Pharma Solutions B.V., Lupin Ltd., Mithra Pharmaceuticals SA, Novo Nordisk AS, Palatin Technologies Inc., Pfizer Inc., Pharmbio Korea Inc., Sprout Pharmaceuticals Inc., Strategic Science and Technologies LLC, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the female sexual dysfunction treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Age Group
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global female sexual dysfunction treatment market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global female sexual dysfunction treatment market 2017 - 2021 ($ million)
• 4.2 Age Group Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Age Group

• 6.1 Market segments
• Exhibit 30: Chart on Age Group - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Age Group - Market share 2022-2027 (%)
• 6.2 Comparison by Age Group
• Exhibit 32: Chart on Comparison by Age Group
• Exhibit 33: Data Table on Comparison by Age Group
• 6.3 Above 40 years - Market size and forecast 2022-2027
• Exhibit 34: Chart on Above 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Above 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Above 40 years - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Above 40 years - Year-over-year growth 2022-2027 (%)
• 6.4 Below 40 years - Market size and forecast 2022-2027
• Exhibit 38: Chart on Below 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Below 40 years - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Below 40 years - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Below 40 years - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Age Group
• Exhibit 42: Market opportunity by Age Group ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 43: Chart on Product - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 45: Chart on Comparison by Product
• Exhibit 46: Data Table on Comparison by Product
• 7.3 Non-hormonal therapy - Market size and forecast 2022-2027
• Exhibit 47: Chart on Non-hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Non-hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Non-hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Non-hormonal therapy - Year-over-year growth 2022-2027 (%)
• 7.4 Hormonal therapy - Market size and forecast 2022-2027
• Exhibit 51: Chart on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Hormonal therapy - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Hormonal therapy - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Product
• Exhibit 55: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 81: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.11 France - Market size and forecast 2022-2027
• Exhibit 93: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 100: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 102: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 103: Matrix on vendor position and classification
• 12.3 Cipla Ltd.
• Exhibit 104: Cipla Ltd. - Overview
• Exhibit 105: Cipla Ltd. - Business segments
• Exhibit 106: Cipla Ltd. - Key news
• Exhibit 107: Cipla Ltd. - Key offerings
• Exhibit 108: Cipla Ltd. - Segment focus
• 12.4 Dare Bioscience Inc.
• Exhibit 109: Dare Bioscience Inc. - Overview
• Exhibit 110: Dare Bioscience Inc. - Product / Service
• Exhibit 111: Dare Bioscience Inc. - Key offerings
• 12.5 Dr Reddys Laboratories Ltd.
• Exhibit 112: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 113: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 114: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 115: Dr Reddys Laboratories Ltd. - Segment focus
• 12.6 Duchesnay Inc.
• Exhibit 116: Duchesnay Inc. - Overview
• Exhibit 117: Duchesnay Inc. - Product / Service
• Exhibit 118: Duchesnay Inc. - Key offerings
• 12.7 Endo International Plc
• Exhibit 119: Endo International Plc - Overview
• Exhibit 120: Endo International Plc - Business segments
• Exhibit 121: Endo International Plc - Key news
• Exhibit 122: Endo International Plc - Key offerings
• Exhibit 123: Endo International Plc - Segment focus
• 12.8 Freya Pharma Solutions B.V.
• Exhibit 124: Freya Pharma Solutions B.V. - Overview
• Exhibit 125: Freya Pharma Solutions B.V. - Product / Service
• Exhibit 126: Freya Pharma Solutions B.V. - Key offerings
• 12.9 Lupin Ltd.
• Exhibit 127: Lupin Ltd. - Overview
• Exhibit 128: Lupin Ltd. - Product / Service
• Exhibit 129: Lupin Ltd. - Key news
• Exhibit 130: Lupin Ltd. - Key offerings
• 12.10 Mithra Pharmaceuticals SA
• Exhibit 131: Mithra Pharmaceuticals SA - Overview
• Exhibit 132: Mithra Pharmaceuticals SA - Product / Service
• Exhibit 133: Mithra Pharmaceuticals SA - Key offerings
• 12.11 Novo Nordisk AS
• Exhibit 134: Novo Nordisk AS - Overview
• Exhibit 135: Novo Nordisk AS - Business segments
• Exhibit 136: Novo Nordisk AS - Key offerings
• Exhibit 137: Novo Nordisk AS - Segment focus
• 12.12 Palatin Technologies Inc.
• Exhibit 138: Palatin Technologies Inc. - Overview
• Exhibit 139: Palatin Technologies Inc. - Product / Service
• Exhibit 140: Palatin Technologies Inc. - Key offerings
• 12.13 Pfizer Inc.
• Exhibit 141: Pfizer Inc. - Overview
• Exhibit 142: Pfizer Inc. - Product / Service
• Exhibit 143: Pfizer Inc. - Key news
• Exhibit 144: Pfizer Inc. - Key offerings
• 12.14 Sprout Pharmaceuticals Inc.
• Exhibit 145: Sprout Pharmaceuticals Inc. - Overview
• Exhibit 146: Sprout Pharmaceuticals Inc. - Product / Service
• Exhibit 147: Sprout Pharmaceuticals Inc. - Key offerings
• 12.15 Strategic Science and Technologies LLC
• Exhibit 148: Strategic Science and Technologies LLC - Overview
• Exhibit 149: Strategic Science and Technologies LLC - Product / Service
• Exhibit 150: Strategic Science and Technologies LLC - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 151: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 152: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 153: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 154: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 155: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
• Exhibit 156: Viatris Inc. - Overview
• Exhibit 157: Viatris Inc. - Business segments
• Exhibit 158: Viatris Inc. - Key offerings
• Exhibit 159: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 160: Inclusions checklist
• Exhibit 161: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 162: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 163: Research methodology
• Exhibit 164: Validation techniques employed for market sizing
• Exhibit 165: Information sources
• 13.5 List of abbreviations
• Exhibit 166: List of abbreviations